Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • diamondmadison diamondmadison Jan 15, 2013 5:54 PM Flag

    JANUARY 18TH HUGE CATALYST FOR ARNA. /// linked

    eeking Alpha
    1/15/13 By: RX Stocks
    Arena's (ARNA) obesity drug, Belviq, was approved on June 27, 2012 and should receive final scheduling by the DEA soon. The DEA recommended Schedule 4 and is collecting comments through January 18, 2013, then a final decision should be forthwith. European approval may also be imminent (see Seeking Alpha), which could be a game changer. Vivus' (VVUS) drug Qsymia did not get European approval, which will give Belviq exclusivity in the European obesity market.

 
ARNA
1.81+0.06(+3.43%)May 31 4:00 PMEDT